Dark

NKTR
Nektar Therapeutics
stock NASDAQ

At Close

Oct 17, 2025 3:59:51 PM EDT

57.70USD+5.043%(+2.77)2,288,406

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 17, 2025 9:16:30 AM EDT

54.68USD-0.455%(-0.25)3,484

After-hours

Oct 17, 2025 4:41:30 PM EDT

57.79USD+0.156%(+0.09)1,839

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.10B

CEO

Howard Robin

Headquarters

San Francisco, California, USA

Industry

Biotechnology

Last Split

Jun 9, 20251for15reverse

AMGN RELL AZN NVS BAX JNJ PFE MRK ALKS XLV

NKTR Stats

Avg. Vol. 10 Day

698,177

Avg. Vol. 30 Day

1,165,264

Employees

509

Market Cap

1,098,893,148

Shares Out.

19,018,573

On/Off Exchange

50%/50%

6 Month Beta

4.75

1 Year Beta

2.08

2 Year Beta

2.07

3 Year Beta

2.05

52 Week Low

6.48

52 Week High

62.95

SMA50

43.70

SMA200

21.59

1 Week

+6.33%

1 Month

+13.14%

3 Month

+116.65%

6 Month

+505.28%

1 Year

+165.66%

2 Year

+587.86%

5 Year

-77.53%

Profile

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

NKTR Stock Summary

Nektar Therapeutics (NASDAQ:NKTR) stock price today is $57.70, and today's volume is 2,288,406. NKTR is up 5.043% today. The 30 day average volume is 1,165,264. NKTR market cap is 1.10B with 19,018,573 shares outstanding.

document.getElementById("ntLqTm").onerror = function(){this.style.display='none';}; .dark-mode .n5XNq3{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .n5XNq3{ color: #333333; background-color: white; border: 2px solid #333333; }NKTRNektar Therapeuticsstock NASDAQ

NKTR Stock Summary

NKTR
Nektar Therapeutics
stock NASDAQ